Electroconvulsive therapy or clozapine for adolescents with treatment-resistant schizophrenia: an explorative analysis on symptom dimensions
Authors:
- 28 December 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Psychiatry in Clinical Practice
- Vol. 27 (3) , 257-263
Abstract
This study sought to compare pre-intervention patient characteristics and post-intervention outcomes in a naturalistic sample of adolescent inpatients with treatment-resistant psychotic symptoms who received either electroconvulsive therapy (ECT) or clozapine. Data of adolescents with schizophrenia/schizoaffective disorder receiving ECT or clozapine were retrospectively collected from two tertiary-care psychiatry-teaching university hospitals. Subscale scores of the Positive and Negative Symptom Scale (PANSS) factors were calculated according to the five-factor solution. Baseline demographics, illness characteristics, and post-intervention outcomes were compared. There was no significant difference between patients receiving ECT (n = 13) and clozapine (n = 66) in terms of age, sex, and the duration of hospital stay. The ECT group more commonly had higher overall illness and aggression severity. Smoking was less frequent in the clozapine group. Baseline resistance/excitement symptom severity was significantly higher in the ECT group, while positive, negative, affect, disorganisation, and total symptom scores were not. Both interventions provided a significant reduction in PANSS scores with large effect sizes. Both ECT and clozapine yielded high effectiveness rates in adolescents with treatment-resistant schizophrenia/schizoaffective disorder. Youth receiving ECT were generally more activated than those who received clozapine.Keywords
This publication has 43 references indexed in Scilit:
- Electroconvulsive Therapy and Clozapine in Adolescents With Schizophrenia Spectrum DisordersJournal of Clinical Psychopharmacology, 2012
- Clinical Experience Using Electroconvulsive Therapy in Adolescents with Schizophrenia Spectrum DisordersJournal of Child and Adolescent Psychopharmacology, 2010
- Retrospective Case Series of Aripiprazole Augmentation in Pervasive Developmental DisordersPsychiatry Investigation, 2010
- Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophreniaEuropean Child & Adolescent Psychiatry, 2009
- Long‐term sustained benefits of clozapine treatment in refractory early onset schizophrenia: A retrospective study in Korean children and adolescentsHuman Psychopharmacology: Clinical and Experimental, 2008
- Comparative Study of Clozapine, Electroshock and the Combination of ECT with Clozapine in Treatment-Resistant Schizophrenic PatientsPakistan Journal of Biological Sciences, 2007
- Neuroleptic Malignant Syndrome Associated with Risperidone in a Male with Early-Onset SchizophreniaJournal of Child and Adolescent Psychopharmacology, 2005
- Psychopathology and treatment responsiveness of patients with first-episode schizophreniaNeuropsychiatric Disease and Treatment, 2005
- Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus HaloperidolAmerican Journal of Psychiatry, 2003
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987